Today’s updates include molecular data from multiple patients demonstrating SERPINA1 delivery and alpha-1 antitrypsin, AAT ... KB408 for the treatment of alzha-1 antitrypsin deficiency lung disease: ...

Krystal Biotech ( (KRYS) ) just unveiled an announcement.

Police have launched an investigation following the sudden death of a schoolgirl. Tilly Fern Wooler was rushed to hospital ...

mezagitamab, an investigational anti-CD38 antibody providing rapid, selective and sustained depletion of disease-causing ...

BEAM appoints Sravan K. Emany as its new chief financial officer, effective Dec. 19. Shares rise on this leadership transition.

A provisional cause of death, provided by pathologists Dr Michael Parsons and Jens Stahlschmidt, was given as 1a, multiple ...

Chronic Obstructive Pulmonary Disease, or COPD, is a serious condition that affects the lungs, making it hard to breathe. It develops slowly over time and is often caused by damage to the airways and ...

In 2024, startups saw a notable resurgence in large-scale funding rounds. By May, over 100 startups had secured funding ...

Fintel reports that on December 9, 2024, Jefferies upgraded their outlook for Vertex Pharmaceuticals (NasdaqGS:VRTX) from ...

Chronic obstructive pulmonary disease (COPD), a significant yet often overlooked health issue in Malaysia due to low awareness and understanding, affects a considerable portion of the population, as ...

alpha-1 AT = alpha-1 antitrypsin; ANA = antinuclear antibodies; SMA = smooth muscle antibodies; anti-LKM1 = antibodies to liver/kidney microsome type 1; AMA = antimitochondrial antibodies ...

Fintel reports that on December 6, 2024, Jefferies initiated coverage of Mereo BioPharma Group plc - Depositary Receipt () ...